# Intarcia Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intarcia-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Boston, US
- Website: www.intarcia.com
- Total disclosed funding: $817M
- Latest round: Series E (Sep 2, 2016)
- Investors on record: 50

## About

Intarcia Therapeutics, Inc., based in the US, focuses on developing innovative drug delivery systems for chronic diseases, aiming to improve patient outcomes through advanced therapeutic solutions.Founded in 1997 and headquartered in Boston, US, Intarcia Therapeutics, Inc. specializes in drug delivery systems. The company has undergone significant developments in its business strategy to enhance its therapeutic offerings. Kurt Graves serves as the CEO. Most recently, Intarcia completed a VENTURE DEBT funding round of USD 125.37 mn, raising a total of USD 48.93 mn to date across 29 deals, with the latest deal occurring on August 28, 2023.Intarcia Therapeutics, Inc. is known for its advanced drug delivery systems designed to improve the treatment of chronic diseases. The company offers innovative solutions that facilitate the effective administration of therapies, focusing on enhancing patient adherence and outcomes.Intarcia generates revenue through the sale of its proprietary drug delivery systems and related services. The company's revenue model is built on direct sales of its products and ongoing collaborations with healthcare systems to implement its solutions.In August 2023, Intarcia Therapeutics was acquired by i2o Therapeutics, Inc., a portfolio company of Sanofi Ventures and JDRF T1D Fund. This acquisition is expected to support the integration of Intarcia's innovative drug delivery systems into broader therapeutic strategies. Future plans include expanding the reach of its products into new markets and enhancing its pipeline with additional therapies designed for chronic conditions.

## Funding rounds

- Series E, Sep 2, 2016, $184M — Baupost Group, Venrock, Quilvest Capital Partners, New Leaf Venture Partners, Fidelity Investments, Baillie Gifford, Foresite Capital, RA Capital Management, The Pritzker Organization, Franklin Templeton, Lucion Venture Capital Group
- Series D, Mar 27, 2014, $200M — Venrock, Quilvest Capital Partners, New Leaf Venture Partners, Fidelity Investments, Foresite Capital, RA Capital Management, Farallon Capital Management, Franklin Templeton, Fred Alger Management
- Series C, Nov 29, 2012, $156M — Alta Partners, New Enterprise Associates, Baupost Group, Venrock, New Leaf Venture Partners, Fidelity Investments, Farallon Capital Management
- Series C, Jan 1, 2012, $84M — Marker
- Series B, Apr 28, 2008, $25M — Alta Partners, InterWest Partners, New Enterprise Associates, Greenspring Associates, Granite Asia, Venrock, Quilvest Capital Partners, New Leaf Venture Partners, Bay City Capital, Teachers' Private Capital
- Series B, Mar 29, 2007, $23M — Alta Partners, InterWest Partners, New Enterprise Associates, Greenspring Associates, Granite Asia, Venrock, Quilvest Capital Partners, New Leaf Venture Partners, Bay City Capital, Teachers' Private Capital, Omega Funds
- Series E, Dec 1, 2004, $50M — Adams Street Partners, Alta Partners, InterWest Partners, New Enterprise Associates, Greenspring Associates, Granite Asia, Venrock, Pac-Link, Teachers' Private Capital, Glynn Capital
- Series D, Jun 30, 2003, $43M — Adams Street Partners, Alta Partners, InterWest Partners, New Enterprise Associates, Venrock, Brentwood Venture Capital, Bay City Capital, JP Morgan Asset Management, Sectoral Asset Management
- Series C, Aug 31, 2000, $38M — Alta Partners, Brentwood Associates, Delphi Ventures, Focus Ventures, InterWest Partners, Charter Life Sciences, Pictet Group, Brentwood Venture Capital, Bay City Capital, Julius Baer Trust and Bank, BSI SA, Trefoil Limited, Raiffeisen Centrobank, Lombard Odier, Triaxis Capital, LGT, Banco Union S.A., Banque SCS Alliance SA, Compagnie Bancaire Helvétique, Esperia Performance Fund, Fidurhône, Garfin, Rastriya Banijya Bank, Swisspartners Investment Network
- Series B, Apr 27, 1999, $12M — Alta Partners, Brentwood Associates, Delphi Ventures, InterWest Partners, Pacific Growth Equities, GC&H Investments
- Series A, Aug 14, 1997, $2M — Brentwood Associates, Delphi Ventures

## Investors

- Brentwood Associates (https://capitalatlas.ai/funds/brentwood-associates) — Series A, Series B, Series C
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series B, Series C
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B, Series C, Series D, Series E
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B, Series C, Series D, Series E
- Pacific Growth Equities — Series B
- GC&H Investments (https://capitalatlas.ai/funds/gc-h-investments) — Series B
- Focus Ventures (https://capitalatlas.ai/funds/focus-ventures) — Series C
- Charter Life Sciences (https://capitalatlas.ai/funds/charter-life-sciences) — Series C
- Pictet Group — Series C
- Brentwood Venture Capital (https://capitalatlas.ai/funds/brentwood-venture-capital) — Series C, Series D
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series C, Series D, Series B
- Julius Baer Trust and Bank — Series C
- BSI SA — Series C
- Trefoil Limited — Series C
- Raiffeisen Centrobank — Series C
- Lombard Odier (https://capitalatlas.ai/funds/lombard-odier) — Series C
- Triaxis Capital (https://capitalatlas.ai/funds/triaxis-capital) — Series C
- LGT — Series C
- Banco Union S.A. — Series C
- Banque SCS Alliance SA — Series C
- Compagnie Bancaire Helvétique — Series C
- Esperia Performance Fund — Series C
- Fidurhône — Series C
- Garfin — Series C
- Rastriya Banijya Bank — Series C
- Swisspartners Investment Network — Series C
- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series D, Series E
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series D, Series E, Series B, Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series D, Series E, Series B, Series C
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series D
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series D
- Greenspring Associates (https://capitalatlas.ai/funds/greenspring-associates) — Series E, Series B
- Granite Asia (https://capitalatlas.ai/funds/granite-asia) — Series E, Series B
- Pac-Link (https://capitalatlas.ai/funds/pac-link) — Series E
- Teachers' Private Capital — Series E, Series B
- Glynn Capital (https://capitalatlas.ai/funds/glynn-capital) — Series E
- Quilvest Capital Partners (https://capitalatlas.ai/funds/quilvest-capital-partners) — Series B, Series D, Series E
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B, Series C, Series D, Series E
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series B
- Marker (https://capitalatlas.ai/funds/marker) — Series C
- Baupost Group — Series C, Series E
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C, Series D, Series E
- Farallon Capital Management (https://capitalatlas.ai/funds/farallon-capital-management) — Series C, Series D
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series D, Series E
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series D, Series E
- Franklin Templeton (https://capitalatlas.ai/funds/franklin-templeton) — Series D, Series E
- Fred Alger Management — Series D
- Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series E
- The Pritzker Organization — Series E
- Lucion Venture Capital Group — Series E